“osteoarthritis” Archives

in
Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Unity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug 09/15/20 San Francisco
Unity Biotech Arthritis Drug Flunks Phase 2, Spelling Program’s End 08/18/20 San Francisco
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Gilead Ups Stake in Galapagos With $5B Deal to Jumpstart Its R&D 07/15/19 San Francisco
Elanco Bolsters Pet Products Pipeline With $234M Deal for Aratana 04/26/19 Indiana
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More 10/26/18 National
Pain Drug Race Continues as Regeneron Posts Early Phase 3 Results 08/16/18 New York
Unity Biotech IPO Raises $85M to Test Drugs for Diseases of Aging 05/02/18 San Francisco
Unity Biotech Files IPO to Bring Anti-Aging Drugs into Clinical Trials 04/06/18 San Francisco
Anti-Aging Startup Unity Bio Grabs $55M, Plans First Clinical Trial 03/19/18 San Francisco
After Strong 2017, Biotechs & Medtechs Start ’18 with Venture, IPO News 01/02/18 National
Regeneron, in Pain Drug Race With Pfizer & Lilly, Gets $250M From Teva 09/20/16 New York
East Coast Biotech Roundup: Homology, Biogen, Intellia & More 05/05/16 Boston
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
Ampio Pharmaceuticals Starts Final Study for Osteoarthritis Treatment 01/15/14 Boulder/Denver
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs 01/08/14 Boston
Flexion’s Long-Lasting Steroid Injection Hits Mark in Phase 2 Trial 06/26/13 Boston
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
Flexion Therapeutics Secures $20 Million to Fight Osteoarthritis 12/04/12 Boston
Flexion Overhaul Bears Fruit With Upbeat Data From Arthritis Trial 05/30/12 Boston
ConforMIS Shapes Corporate Expansion with $50M D Round 07/13/09 Boston
Former CEO Alexis Borisy Voices Mixed Feelings on CombinatoRx Saga 07/06/09 Boston
Genzyme Nabs Two Key Regulatory Approvals, Expected to Trigger Revenue Growth 02/26/09 Boston
FDA Panel Gives Nod to Genzyme Osteoarthritis Treatment 12/09/08 Boston
Page 1 of 2 next page »